Articles & Poster Presentations

Home › › Articles & Poster Presentations
  1. Buchta, C., Marrington, R., De la Salle, B. and Albarède, S., Badrick, T., Bullock, D., Cadamuro, J., Delatour, V., Dusinovic, E., Geilenkeuser, WJ., Gidske, G., Griesmacher, A., Haliassos, A.,  Holzhauser, D.,  Huggett, J., Karathanos, S., Pezzati, P., Sandberg, S., Sarkar, A.,  Solsvik, A., Spannagl, M., Thelen, M.,  Restelli, V.,  Perrone, L.A..  Behind the Scenes of EQA – Characteristics, Capabilities, Benefits and Assets of External Quality Assessment (EQA), Part I – EQA in General and EQA Programs in Particular. Clin Chem Lab Med. 2025 Jan 6;63(5):844-858. https://doi.org/10.1515/cclm-2024-1289
  2. Buchta, C., De la Salle, B., Marrington,R., Almonacid, A.A., Albarède, S., Badrick, T., Bullock, D.,  Cobbaert, C.M., Coucke, W., Delatour, V., Faria, AP., Geilenkeuser, WJ., Griesmacher, A., Huggett, JF., Kammel, M., Kessler, A., Körmöczi, GF., Meijer,P., Miranda, A., Patel, D., Pezzati, P., Sandberg, S., Schennach, H., Schweiger, CR., Schwenoha, K., Spannagl, M., Sung, H.,Thelen, M., Weykamp, C., Yanovska, V., Zeichhardt, H., Restelli, V., Perrone, L.A.. Behind the scenes of EQA – Characteristics, Capabilities, Benefits and Assets of External Quality Assessment (EQA), Part II – EQA cycle. Clin Chem Lab Med. vol. 63, no. 5, 2025, pp. 859-867. https://doi.org/10.1515/cclm-2024-1290
  3. Buchta, C., Marrington, R., De la Salle, B. , Albarède, S.,  Albe, X., Badrick, T., Berghäll, H., Bullock, D., Cobbaert, C.M., Coucke, W., Delatour, Vi., Geilenkeuser, WJ., Griesmacher, A., Henriksen, GM., Huggett, JF. , Juhos, I.,  Kammel, M., Luppa, P.B., Meijer, P. Pelanti, J.,  Pezzati, P., Sandberg, S., Spannagl, M.,  Thelen, M., Zeichhardt, H.,  Restelli, V.,  Perrone, L.A.  Behind the scenes of EQA – Characteristics, Capabilities, Benefits and Assets of External Quality Assessment (EQA), Part III – EQA samples. Clin Chem Lab Med. vol. 63, no. 5, 2025, pp. 868-878. https://doi.org/10.1515/cclm-2024-1291
  4. Buchta, C.,  De la Salle, B.,  Marrington, R., Aburto Almonacid, Andrés, Albarède, S.,  Badrick, T., Bullock, D., Cobbaert, C. M., Coucke, W.,  Delatour, V.,  Faria, A.P., Geilenkeuser, W.J., Griesmacher, A., Huggett, J. F., Kammel, M.,  Kessler, A., Körmöczi, G.F., Meijer, P., Miranda, A., Patel, D., Pezzati, P., Sandberg, S., Schennach, H., Schweiger, C.R., Schwenoha, K., Spannagl, M., Sung, H., Thelen, M., Weykamp, C., Yanovska, V., Zeichhardt, H., Restelli, V., Perrone, L.A.. Behind the scenes of EQA–characteristics, capabilities, benefits and assets of external quality assessment (EQA) Part IV – Benefits for participant laboratories. Clin Chem Lab Med. vol. 63, no. 5, 2025, pp. 879-897. https://doi.org/10.1515/cclm-2024-1292
  5. Buchta, C.,  De la Salle, B.,  Marrington, R., Aburto Almonacid, Andrés, Albarède, S.,  Badrick, T., Bullock, D., Cobbaert, C. M., Coucke, W.,  Delatour, V.,  Faria, A.P., Geilenkeuser, W.J., Griesmacher, A., Huggett, J. F., Kammel, M.,  Kessler, A., Körmöczi, G.F., Meijer, P., Miranda, A., Patel, D., Pezzati, P., Sandberg, S., Schennach, H., Schweiger, C.R., Schwenoha, K., Spannagl, M., Sung, H., Thelen, M., Weykamp, C., Yanovska, V., Zeichhardt, H., Restelli, V., Perrone, L.A.. Behind the scenes of EQA – Characteristics, Capabilities, Benefits and Assets of External Quality Assessment (EQA) Part V – Benefits for Stakeholders Other than Participants. Clin Chem Lab Med. vol. 63, no. 5, 2025, pp. 898-915. https://doi.org/10.1515/cclm-2024-1293
  6. *Wu, J., Alam, M.S., Restelli, V., Vimalanathan, S., Perrone, L.A..Evaluation of clinical microbiology laboratory performance through participation in an external quality assessment (EQA) program highlights the need for ongoing support regarding antibiotic susceptibility testing and results interpretation: A 5-year retrospective analysis. J Med Microbiol. 2024 Oct 29;73(10):001915. https://doi.org/10.1099/jmm.0.001915  
  7. Sreya, M., Alam, MD. S., Daula, S., Lee, C., Restelli, V., Middlebrook, K., Noble, M.A., Perrone, L.A.. Participation in a proficiency testing program promotes the quality of drinking-water testing and public safety. Front. Mol. Biosci. 2024. 11:1338549. https://doi.org/10.3389/fmolb.2024.1338549.
  8. Restelli, V., Vimalanathan, S., Sreya, M., Noble, M.A., Perrone, L.A. Ensuring diagnostic testing accuracy for patient care and public health- COVID-19 testing scale-up from an EQA provider’s perspective. PLOS Glob Public Health. 2023. 3(12): e0001615. https://doi.org/10.1371/journal.pgph.0001615.
  9. Buchta, C., Zeichhardt, H., Osterman, A., Perrone, L.A., Griesmacher, A. Do not blindly trust negative diagnostic test results! Lancet Microbe, November 14, 2023. https://doi.org/10.1016/S2666-5247(23)00340-3.
  10. Noble M.A. 2015. Chapter 12. Prevention of Laboratory-Acquired Infections. Manual of Clinical Microbiology 11th Edition.   Edited by: James H. Jorgensen, Michael A. Pfaller, et. al. American Society for Microbiology, Washington DC. 2015
  11. Restelli V, Noble MA 2014. Performance of Canadian clinical laboratories processing throat culture proficiency testing surveys, Accreditation and Quality Assurance. (2014) 19:445–450; (Published online: 15 October 2014)
  12. Michael A Noble, Robert Martin. 2014. Editorial – Making Great Strides in Medical Laboratory Quality. African Journal for Laboratory Medicine. V3 N2 pg2-3.